ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR+66.2%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
+66.2%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
12.7x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202512.21%
202441.94%
202318.99%
2022-1.49%
202167.31%
20200.96%
20196.08%
20184.48%
201727.65%
201613.18%